Napo Pharmaceuticals
Crofelemer
A proprietary gastro-intestinal compound in clinical development for four distinct product indications
 |
 |
 |
|
||
 |
|
 |
|
||
alliances
Napo has formed partnerships for its products based on appropriateness for certain indications in specific geographic targets. Napo’s partners are:
- Glenmark Pharmaceuticals Ltd.
- AsiaPharm
The company believes that these partnerships allow Napo to share clinical and
commercialization risks with reduced cash requirement from Napo. In addition, Napo
can access relevant expertise, such as GMP manufacturing, local market registration
and distribution capabilities.
Napo’s strategy for high value markets is profit sharing and, for high volume markets,
a royalty on sales.